Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer

OBJECTIVE: To evaluate the efficacy and safety of PLD in treating of in patients who experience epithelial ovarian, fallopian tubal, and peritoneal cancer progression within 12 months after the first-line platinum-based therapy. METHODS: This was an open-label, single-arm and multicenter clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zhen, Zhang, Ying, Cao, Dongyan, Shen, Keng, Li, Qingshui, Zhang, Guonan, Wu, Xiaohua, Cui, Manhua, Yue, Ying, Cheng, Wenjun, Wang, Li, Qu, Pengpeng, Tao, Guangshi, Hou, Jianqing, Sun, Lixin, Meng, Yuanguang, Li, Guiling, Li, Changzhong, Shi, Huirong, Chen, Yaqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798203/
https://www.ncbi.nlm.nih.gov/pubmed/33423683
http://dx.doi.org/10.1186/s13048-020-00736-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798203/
https://www.ncbi.nlm.nih.gov/pubmed/33423683
http://dx.doi.org/10.1186/s13048-020-00736-2

Ejemplares similares